News
Anti-inflammatory molecules that treat cystic fibrosis may fight COVID-19
By Sarah Marshall, Uniformed Services University of the Health Sciences WASHINGTON -- Efforts are underway at the Uniformed Services University of the Health Sciences to support the fight against the pandemic, including some that apply existing research and knowledge...
CEO Bill Malkes featured on Startup Knox Podcast
You don't want to miss this interview by Brandon Bruce of Startup Knox with Knoxville serial entrepreneur Bill Malkes about his newest company NellOne Therapeutics. Click to view podcast on original website
NellOne Therapeutics secures key patent to revolutionize large-scale production
NellOne Therapeutics Inc., the early stage biopharmaceutical company using a talented protein to plot a new future for regenerative medicine, today announced that the United States Patent and Trademark Office (“USPTO”) yesterday issued U.S. Patent No. 10,752,663 with...
NellOne Therapeutics and Mayor Jacobs announce plans for new Knox County research and development laboratory
NellOne Therapeutics Inc., the early stage biopharmaceutical company pioneering advances in regenerative medicine, will open a new research and development laboratory in Knox County, it was announced today. The facility will enable NellOne to add up to 20 new jobs...
NellOne Therapeutics files COVID-19 treatment patent
NellOne Therapeutics Inc., the early stage biopharmaceutical company using a talented protein to plot a new future for regenerative medicine, announced today the filing of a provisional patent application around the usage of the NELL1 signaling protein in the...
GRIDSMART Technology Inc Founder Bill Malkes named CEO of NellOne Therapeutics
NellOne Therapeutics Inc., the early stage biopharmaceutical company using a talented protein to plot a new future for regenerative medicine, has appointed accomplished leader and entrepreneur William A. Malkes as its new Chief Executive Officer. NellOne Therapeutics...